Teva Pharmaceutical Industries shares owned by Prospera Financial Services
Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Prospera Financial Services
from 13F filings
Historical chart of Prospera Financial Services investment in Teva Pharmaceutical Industries
Tip: Access up to 7 years of quarterly data
All positions including Teva Pharmaceutical Industries held by Prospera Financial Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Teva Pharmaceutical Industries by Prospera Financial Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $5.1M | 163k | 31.21 |
| 2025-09-30 | $1.3M | 66k | 20.20 |
| 2025-06-30 | $385k | 23k | 16.76 |
| 2025-03-31 | $363k | 24k | 15.37 |
| 2024-12-31 | $514k | 23k | 22.04 |
| 2024-09-30 | $751k | 42k | 18.02 |
| 2024-06-30 | $904k | 56k | 16.25 |
| 2024-03-31 | $1.1M | 76k | 14.11 |
| 2023-12-31 | $490k | 47k | 10.44 |
| 2023-09-30 | $489k | 48k | 10.20 |
| 2023-06-30 | $367k | 49k | 7.53 |
| 2023-03-31 | $848k | 96k | 8.85 |
| 2022-12-31 | $451k | 50k | 9.12 |
| 2022-09-30 | $499k | 62k | 8.07 |
| 2022-06-30 | $260k | 35k | 7.51 |
| 2022-03-31 | $414k | 44k | 9.39 |
| 2021-12-31 | $218k | 27k | 8.02 |
| 2021-09-30 | $552k | 57k | 9.74 |
| 2021-06-30 | $612k | 62k | 9.90 |
| 2021-03-31 | $739k | 64k | 11.55 |
| 2020-12-31 | $422k | 44k | 9.65 |
| 2020-09-30 | $12k | 1.4k | 8.73 |
| 2020-06-30 | $548k | 44k | 12.34 |
| 2020-03-31 | $380k | 42k | 8.98 |
| 2019-12-31 | $593k | 61k | 9.80 |
| 2019-09-30 | $281k | 41k | 6.87 |
| 2019-06-30 | $333k | 36k | 9.35 |
| 2018-12-31 | $541k | 34k | 16.14 |
| 2018-09-30 | $535k | 24k | 21.96 |
| 2018-06-30 | $385k | 16k | 24.00 |
| 2017-03-31 | $245k | 7.6k | 32.06 |
| 2016-12-31 | $286k | 7.8k | 36.73 |
More positions owned by Prospera Financial Services
View all positions for Prospera Financial Services
Top funds holding Teva Pharmaceutical Industries
View all funds holding Teva Pharmaceutical Industries